Patient Engagement Roundtable: Novartis
BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME Patient Engagement Roundtable: A Varied Global Picture As complex cutting-edge therapies come online, industry sponsors are increasingly…
BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME Patient Engagement Roundtable: A Varied Global Picture As complex cutting-edge therapies come online, industry sponsors are increasingly…
BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME CGT, Real World Evidence & The Patient Experience One of the enduring conundrums around ground-breaking and potentially…
BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME CAR-T and the Art of Managing Expectations Chimeric antigen receptor (CAR-T) therapy was first approved by the…
BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME Rendering CGT Genuinely Patient Centric In recent years, the much-discussed concept of “patient centricity” has been top-of-mind…
BACK TO HOME Patient Engagement in the Era of CAR-T BACK TO HOME Marc Boutin Global Head of Patient Engagement, novartis Marc Boutin on 16.11.2021 SHARE “How are you today?”…
HOMEPAGE Patient Engagement in the Era of CAR-T In recent years, the much-discussed concept of “patient centricity” has been top-of-mind across all corners of the pharma industry. This is especially…
BACK TO HOME Cannabis BACK TO HOME The Cannabis Companies Behaving Like Biotechs While many Canadian medical cannabis outfits cover the entire value chain, from research and development through to…
BACK TO HOME Cannabis BACK TO HOME The Medical Cannabis Investment Landscape David H. Crean, managing director for Objective Capital Partners, highlights the progress that has been made over the past…
BACK TO HOME Cannabis BACK TO HOME Canada’s Cannabis Pioneers Go Global As Canada’s emergent medical cannabis industry develops at home, several of the country’s leading companies are seizing opportunities…
BACK TO HOME Cannabis BACK TO HOME Company Profile: GW Pharmaceuticals Founded in 1998, GW Pharmaceuticals is a British biopharmaceutical company, best known for being the only company with a license to…
BACK TO HOME Cannabis BACK TO HOME Five Emerging Trends in Medical Cannabis Five of the key emerging trends in the booming global medical cannabis and cannabinoid medicine industries. Five…
BACK TO HOME Cannabis BACK TO HOME Patents: A Key Factor in Winning the Cannabis Arms Race A new white paper from Fasken law firm asserts that the early filing of…
See our Cookie Privacy Policy Here